Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescent Lectin for Colorectal Lesion Identification
NCT03070613Phase 1Unknown
- Sponsor
- University of Oxford
- Start
- Apr 2017
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in colorectal cancer (CRC), Colorectal Dysplasia and colorectal polyp, sponsored by University of Oxford. Primary endpoints: Signal to background ratio and Number of dysplastic and cancerous lesions identified. Status: unknown.
02
Conditions
colorectal cancer (CRC)Colorectal Dysplasiacolorectal polyp
Beyond the preview
Go deeper on NCT03070613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070613.